We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+25.85%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.59B
(+14%)
Cap. Flow
-$141M
Cap. Flow
% of AUM
-0.67%
Top 10 Holdings %
Top 10 Hldgs %
31.39%
Holding
542
New
4
Increased
254
Reduced
230
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$95.8M |
| 2 |
GE Aerospace
GE
|
+$32.3M |
| 3 |
Tesla
TSLA
|
+$28.7M |
| 4 |
Gilead Sciences
GILD
|
+$26.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$22.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$216M |
| 2 |
Eli Lilly
LLY
|
+$71.6M |
| 3 |
NVIDIA
NVDA
|
+$51.4M |
| 4 |
UnitedHealth
UNH
|
+$43.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$37.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.69% |
| 2 | Financials | 12.52% |
| 3 | Healthcare | 11.04% |
| 4 | Communication Services | 10.22% |
| 5 | Consumer Discretionary | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CSX Corp
CSX
$89.8B
| $26.7M | 0.13% |
561,391
+21,958
| +4% | +$991K |
|
152
Regeneron Pharmaceuticals
REGN
$80.1B
| $26.7M | 0.13% |
42,742
+12,040
| +39% | +$8.2M |
|
153
HCA Healthcare
HCA
$91.9B
| $26.5M | 0.13% |
68,019
+480
| +0.7% | +$203K |
|
154
Church & Dwight Co
CHD
$22.4B
| $26.5M | 0.13% |
273,243
+8,600
| +3% | +$822K |
|
155
Illinois Tool Works
ITW
$76B
| $26.1M | 0.12% |
96,432
+360
| +0.4% | +$93.4K |
|
|
WCN
156
Waste Connections
WCN
$40.4B
| $26M | 0.12% |
155,950
+4,800
| +3% | +$760K |
|
157
Cardinal Health
CAH
$54.3B
| $25.6M | 0.12% |
107,800
-8,200
| -7% | -$1.7M |
|
158
Cigna
CI
$76.3B
| $25.6M | 0.12% |
92,847
-960
| -1% | -$271K |
|
159
Stryker
SYK
$107B
| $25.4M | 0.12% |
80,780
+720
| +0.9% | +$227K |
|
160
Bloom Energy
BE
$78B
| $25.2M | 0.12% |
83,100
+13,400
| +19% | +$3.43M |
|
161
Emerson Electric
EMR
$81.6B
| $25.1M | 0.12% |
175,417
+13,000
| +8% | +$1.83M |
|
162
Ciena
CIEN
$46.5B
| $24.8M | 0.12% |
50,630
+11,280
| +29% | +$5.75M |
|
163
Comcast
CMCSA
$87.6B
| $24.8M | 0.12% |
1,011,215
+42,100
| +4% | +$1.09M |
|
164
Norfolk Southern
NSC
$71.6B
| $24.5M | 0.12% |
78,032
+9,280
| +13% | +$2.86M |
|
165
Fastenal
FAST
$56.3B
| $24.5M | 0.12% |
510,385
+35,000
| +7% | +$1.59M |
|
166
PNC Financial Services
PNC
$96.4B
| $24.4M | 0.12% |
98,933
+6,300
| +7% | +$1.41M |
|
167
Edwards Lifesciences
EW
$49.2B
| $24.1M | 0.12% |
266,335
-7,400
| -3% | -$620K |
|
168
W.W. Grainger
GWW
$60B
| $23.9M | 0.11% |
17,591
+330
| +2% | +$407K |
|
|
BNY
169
Bank of New York Mellon
BNY
$104B
| $23.9M | 0.11% |
165,427
+2,100
| +1% | +$287K |
|
170
Autodesk
ADSK
$47.5B
| $23.8M | 0.11% |
122,542
-8,680
| -7% | -$1.98M |
|
171
NiSource
NI
$19.7B
| $23.4M | 0.11% |
493,050
+150,000
| +44% | +$7.1M |
|
172
Hershey
HSY
$34.5B
| $23.1M | 0.11% |
131,919
+22,600
| +21% | +$4.26M |
|
173
Sherwin-Williams
SHW
$78B
| $23.1M | 0.11% |
66,953
-5,540
| -8% | -$1.77M |
|
174
Medtronic
MDT
$119B
| $23M | 0.11% |
293,866
+1,087
| +0.4% | +$87.7K |
|
175
Blackstone
BX
$95.4B
| $22.9M | 0.11% |
194,922
+18,400
| +10% | +$2.21M |
|
Similar funds
HNB
COPPSERS
HIIFS
RAM
AA
IG
LCIP
Fjarde Ap-fonden's Q2 2026 Portfolio in Review
As of Q2 2026, Fjarde Ap-fonden held 542 positions worth $20.9B, up 14% from $18.3B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 3.9%. Fjarde Ap-fonden opened 4 new positions and exited 17, leaving the 542-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Financials and Healthcare.
- Fjarde Ap-fonden's largest Q2 2026 buy was Circle Internet Group: 45,100 shares worth $2.82M.
- Fjarde Ap-fonden added most to Broadcom in Q2 2026, an estimated $95.8M increase.
- Fjarde Ap-fonden's biggest Q2 2026 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $216M.
- Fjarde Ap-fonden fully exited Southern Company in Q2 2026, selling an estimated $20M.
- Fjarde Ap-fonden's ten largest holdings make up 31% of its $20.9B portfolio in Q2 2026.
- Fjarde Ap-fonden opened 4 new positions and closed 17 in Q2 2026.
- Fjarde Ap-fonden's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.